Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -520,121 | -307,291 | -140,718 | -463,927 | -326,847 |
| Depreciation Amortization | 3,390 | 457 | -39 | -22,859 | -15,968 |
| Accounts payable and accrued liabilities | -1,761 | -19,638 | -29,163 | 34,584 | 3,275 |
| Other Working Capital | 16,251 | -15,824 | -49,515 | -54,895 | -52,410 |
| Other Operating Activity | 71,496 | 54,856 | 53,161 | 54,470 | 50,724 |
| Operating Cash Flow | $-430,745 | $-287,440 | $-166,274 | $-452,627 | $-341,226 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -918,850 | -663,535 | -314,485 | -3,086,701 | -2,271,486 |
| PPE Investments | -11,059 | -7,235 | -5,424 | -22,427 | -18,406 |
| Sale Of Investment | 1,289,631 | 901,100 | 464,553 | 1,200,194 | 912,120 |
| Other Investing Activity | -37,493 | -29,271 | -21,327 | -96,732 | -70,726 |
| Investing Cash Flow | $322,229 | $201,059 | $123,317 | $-2,005,666 | $-1,448,498 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,590 | 9,284 | 6,049 | 2,435,656 | 2,456,808 |
| Other Financing Activity | -9,984 | -6,007 | -5,290 | 12,852 | -13,207 |
| Financing Cash Flow | $-394 | $3,277 | $759 | $2,448,508 | $2,443,601 |
| Exchange Rate Effect | 2,263 | 1,972 | 1,172 | 426 | -924 |
| Beginning Cash Position | 389,195 | 389,195 | 389,195 | 398,554 | 398,554 |
| End Cash Position | 282,548 | 308,063 | 348,169 | 389,195 | 1,051,507 |
| Net Cash Flow | $-106,647 | $-81,132 | $-41,026 | $-9,359 | $652,953 |
| Free Cash Flow | |||||
| Operating Cash Flow | -430,745 | -287,440 | -166,274 | -452,627 | -341,226 |
| Capital Expenditure | -11,059 | -7,235 | -5,424 | -22,427 | -18,406 |
| Free Cash Flow | -441,804 | -294,675 | -171,698 | -475,054 | -359,632 |